Coya Therapeutics, Inc.(COYA)
$3.00-0.13 (-4.15%)
COYA
Coya Therapeutics, Inc. financials statements
$3.00
At close:-0.13 (-4.15%)
Want to see COYA full AI Analyst Report?
Coya Therapeutics, Inc. (COYA) Ratios
129 Followers
Coya Therapeutics, Inc. Ratios
COYA's free cash flow for Q3 2026 was $-6.35M. For the 2026 fiscal year, COYA's free cash flow was increased by $885.00K and operating cash flow was $-7.24M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 8.50 | 11.59 | 8.15 | 1.88 | 3.99 |
| Quick Ratio | 8.50 | 11.59 | 8.15 | 1.88 | 3.99 |
| Cash Ratio | 7.97 | 10.02 | 6.46 | 1.55 | 3.78 |
| Solvency Ratio | -3.06 | -3.11 | -1.41 | -0.73 | -4.25 |
| Operating Cash Flow Ratio | -1.83 | -2.69 | -2.21 | -1.89 | -3.40 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 43.02M | $ 39.54M | $ 35.57M | $ -9.60M | $ 3.44M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 1.54 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | -1.54 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 2.84 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 2.84 | 0.00 |
| Financial Leverage Ratio | 1.16 | 1.12 | 1.16 | -1.00 | 1.32 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.28 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 1.30 | 0.00 |
| Net Debt to EBITDA | 2.21 | 2.23 | 4.45 | -0.76 | 0.89 |
| Profitability Margins | |||||
| Gross Profit Margin | 99.66% | -233.86% | 8.34% | 0.00% | 0.00% |
| EBIT Margin | -267.10% | -484.65% | -122.62% | 0.00% | 0.00% |
| EBITDA Margin | -266.75% | -483.88% | -122.17% | 0.00% | 0.00% |
| Operating Profit Margin | -255.05% | -485.35% | -131.67% | 0.00% | 0.00% |
| Pretax Profit Margin | -267.10% | -438.96% | -121.02% | 0.00% | 0.00% |
| Net Profit Margin | -267.14% | -418.70% | -133.08% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -267.14% | -418.70% | -133.08% | 0.00% | 0.00% |
| Net Income Per EBT | 100.01% | 95.38% | 109.96% | 100.00% | 100.00% |
| EBT Per EBIT | 104.72% | 90.44% | 91.91% | 124.79% | 100.44% |
| Return on Assets (ROA) | -42.49% | -33.56% | -19.36% | -145.85% | -102.08% |
| Return on Equity (ROE) | -49.33% | -37.60% | -22.42% | 145.88% | -134.25% |
| Return on Capital Employed (ROCE) | -45.98% | -42.57% | -21.83% | -214.61% | -133.66% |
| Return on Invested Capital (ROIC) | -45.98% | -40.60% | -21.83% | -214.61% | -133.66% |
| Return on Tangible Assets | -42.49% | -33.56% | -19.36% | -145.85% | -102.08% |
| Earnings Yield | -21.87% | -17.04% | -10.61% | -25.98% | -16.21% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 4.86 | 0.80 | 0.00 | 0.00 |
| Payables Turnover | 0.03 | 7.47 | 4.76 | 2.43 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 707.74 | 92.10 | 91.01 | 0.00 | 0.00 |
| Asset Turnover | 0.16 | 0.08 | 0.15 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.19 | 0.09 | 0.30 | 0.00 | 0.00 |
| Cash Conversion Cycle | -14155.53 | 26.18 | 379.41 | -150.16 | 0.00 |
| Days of Sales Outstanding | 0.00 | 75.03 | 456.08 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 14155.53 | 48.85 | 76.67 | 150.16 | 0.00 |
| Operating Cycle | 0.00 | 75.03 | 456.08 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.64 | -0.68 | -1.10 | -0.73 | -0.59 |
| Free Cash Flow Per Share | -0.64 | -0.68 | -1.10 | -0.73 | -0.61 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -28.53 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -28.53 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | -0.56 | 0.00 |
| Operating Cash Flow to Sales Ratio | -1.35 | -2.89 | -1.86 | 0.00 | 0.00 |
| Free Cash Flow Yield | -11.07% | -11.78% | -14.86% | -15.36% | -13.39% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.57 | -5.87 | -9.43 | -3.85 | -6.17 |
| Price-to-Sales (P/S) Ratio | 12.21 | 24.57 | 12.55 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 2.26 | 2.21 | 2.11 | -5.62 | 8.28 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -9.04 | -8.49 | -6.73 | -6.51 | -7.47 |
| Price-to-Operating Cash Flow Ratio | -9.04 | -8.49 | -6.73 | -6.51 | -7.73 |
| Price-to-Earnings Growth (PEG) Ratio | -0.15 | -0.24 | 0.26 | -0.06 | -0.08 |
| Enterprise Value Multiple | -2.37 | -2.85 | -5.82 | -5.85 | -5.32 |
| Enterprise Value | 50.21M | 48.98M | 42.69M | 54.17M | 25.84M |
| EV to EBITDA | -2.37 | -2.85 | -5.82 | -5.85 | -5.32 |
| EV to Sales | 6.32 | 13.78 | 7.11 | 0.00 | 0.00 |
| EV to Free Cash Flow | -4.68 | -4.76 | -3.82 | -7.48 | -6.39 |
| EV to Operating Cash Flow | -4.68 | -4.76 | -3.82 | -7.48 | -6.62 |
| Tangible Book Value Per Share | 2.57 | 2.60 | 3.51 | -0.84 | 0.55 |
| Shareholders’ Equity Per Share | 2.57 | 2.60 | 3.51 | -0.84 | 0.55 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.05 | -0.10 | 0.00 | 0.00 |
| Revenue Per Share | 0.47 | 0.23 | 0.59 | 0.00 | 0.00 |
| Net Income Per Share | -1.27 | -0.98 | -0.79 | -1.23 | -0.74 |
| Tax Burden | 1.00 | 0.95 | 1.10 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 0.91 | 0.99 | 1.32 | 1.00 |
| Research & Development to Revenue | 2.11 | 3.35 | 1.01 | 0.00 | 0.00 |
| SG&A to Revenue | 1.44 | 2.50 | 1.31 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.54 | 0.75 | 0.15 | 0.00 | 0.00 |
| Income Quality | 0.51 | 0.69 | 1.40 | 0.59 | 0.80 |
Currency in USD

